Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Aptamin C® enhances vitamin C's antioxidant effects, benefiting skin by reducing oxidative stress and inflammation.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Cepharanthine could be a strong antiviral against COVID-19.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

New medications could improve treatment for severe alopecia areata in Australia.

Baricitinib is an effective treatment for severe alopecia areata.

Shikimic acid promotes hair growth.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Potassium channel openers help form elastic fibers in arteries and can treat elastin deficiency and hypertension.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

p21waf1/cip1 and p27kip1 help in hair follicle differentiation in rats.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

A peptide in shampoo can promote hair growth and improve hair condition.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Baricitinib shows promise for treating alopecia areata with mild side effects.

A new method accurately detects illegal JAK inhibitors in hair loss cosmetics.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

JAK inhibitors show promise as a future treatment for hair loss.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Kangfuxin (KFX) extract speeds up wound healing and improves skin regeneration.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

JAK inhibitors might help treat alopecia areata.